Skip to main content
Sunshine Biopharma Inc. logo

Sunshine Biopharma Inc. — Investor Relations & Filings

Ticker · SBFM ISIN · US8677817004 LEI · 5299005Y64EHRQDQ2Q25 US Manufacturing
Open in API
Filings indexed 382 across all filing types
Latest filing 2009-10-19 Board/Management Inform…
Country US United States of America
Listing US SBFM

About Sunshine Biopharma Inc.

https://www.sunshinebiopharma.com/

Sunshine Biopharma Inc. is a pharmaceutical company engaged in the research, development, and commercialization of life-saving medicines. The company's primary focus is on various therapeutic areas, with a significant emphasis on oncology and antiviral treatments.

Recent filings

Filing Released Lang Actions
FORM 8-K DATED OCTOBER 15, 2009
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated October 15, 2009. It reports significant corporate events including the completion of an acquisition, changes in control of the registrant, issuance of equity securities, and changes in management. The content includes detailed descriptions of the acquisition of Sunshine Biopharma, Inc., changes in officers and directors, and business plan revisions. There are no comprehensive financial statements or detailed financial performance data typical of Annual Reports (10-K) or Interim Reports (IR). The document primarily announces corporate events and management changes rather than presenting financial results or audit information. Therefore, the most appropriate classification is "Board/Management Information (MANG)" as it includes changes in the company's board and senior management and related corporate actions.
2009-10-19 English
QUARTERLY REPORT
Interim / Quarterly Report 9M 2009
2009-06-15 English
QUARTERLY REPORT
Interim / Quarterly Report Q2 2009
2009-03-16 English
QUARTERLY REPORT
Interim / Quarterly Report Q1 2009
2008-12-09 English
ANNUAL REPORT FOR YEAR ENDED JULY 31, 2008
Annual Report Classification · 100% confidence The document is titled 'FORM 10-KSB' and is described as an 'Annual Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Fiscal Year Ended: July 31, 2008.' It contains detailed sections typical of an annual report, including business description, risk factors, management discussion and analysis, financial statements, and executive compensation. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. The presence of financial data and comprehensive company information confirms it is the official annual report filing. Therefore, the document is classified as an Annual Report (10-K).
2008-10-28 English
AMENDMENT #1 TO 10-QSB ENDED 1-31-08
Interim / Quarterly Report Classification · 100% confidence The document is titled 'FORM 10-QSB/A' and is an amendment to a quarterly report for the period ended January 31, 2008. It contains detailed unaudited financial statements including balance sheets, statements of operations, shareholders' equity, cash flows, and notes to the financial statements. It also includes management's discussion and analysis (MD&A) of financial condition and results of operations. The presence of comprehensive financial data and MD&A for a quarterly period clearly identifies this as an Interim / Quarterly Report. The document is not a brief announcement or a certification letter, but a full quarterly filing with substantive financial information. Therefore, the correct classification is 'IR' (Interim / Quarterly Report).
2008-06-12 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.